The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
CVS Health exceeded second-quarter 2026 earnings and revenue estimates, with all business segments performing above expectations. The company raised its 2026 guidance due to recovery in the Aetna unit, despite lowering full-year earnings projections. CVS stock fell 4.65% amid rising medical benefit ratios, while Newmont and Walt Disney shares rose following strong performance in gold prices and streaming margins.